A phase I of TG6050 in the treatment of patients with metastatic lung cancer

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513093-22-00

Acronym

TG6050.01

Enrollment

Registered

2024-07-03

Start date

2023-03-27

Completion date

2025-06-23

Last updated

2025-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer (NSCLC)

None listed

Sex/Gender

All

Age

18 Years to No maximum

France

None listed

Source: EU CTIS · Data processed: Feb 4, 2026